Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-26 Purchase |
2025-03-28 5:50 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
22,640 | $1.0417 | $23,584 | 735,683 (Direct) |
View |
2025-03-26 Purchase |
2025-03-28 5:48 pm |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
9,056 | $1.0417 | $9,434 | 83,577 (Direct) |
View |
2025-03-26 Purchase |
2025-03-28 5:41 pm |
Oncology Institute Inc. | TOI | Pacala Mark L Director |
90,562 | $1.0417 | $94,338 | 267,252 (Indirect) |
View |
2025-03-26 Purchase |
2025-03-28 5:36 pm |
Oncology Institute Inc. | TOI | Johnson Karen Marie Director |
36,224 | $1.0417 | $37,735 | 221,521 (Direct) |
View |
2025-03-26 Purchase |
2025-03-28 5:34 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
9,056 | $1.0417 | $9,434 | 680,337 (Direct) |
View |
2025-03-26 Purchase |
2025-03-28 5:33 pm |
Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer |
9,056 | $1.0417 | $9,434 | 94,914 (Direct) |
View |
2025-03-26 Purchase |
2025-03-28 5:27 pm |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
9,056 | $1.0417 | $9,434 | 43,935 (Direct) |
View |
2025-03-26 Purchase |
2025-03-28 5:25 pm |
Oncology Institute Inc. | TOI | BARASCH RICHARD A Director |
1,358,448 | $1.0417 | $1,415,095 | 2,454,865 (Indirect) |
View |
2025-03-19 Sale |
2025-03-20 6:01 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
10,261 | $0.889 | $9,122 | 701,723 (Direct) |
View |
2025-03-19 Sale |
2025-03-20 5:58 pm |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
2,975 | $0.889 | $2,645 | 69,993 (Direct) |
View |
2025-03-19 Sale |
2025-03-20 5:56 pm |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
1,150 | $0.889 | $1,022 | 30,351 (Direct) |
View |
2025-01-06 Sale |
2025-01-07 1:18 pm |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
258 | $0.335 | $86 | 31,501 (Direct) |
View |
2024-12-03 Sale |
2024-12-05 4:02 pm |
Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer |
1,130 | $0.16 | $181 | 81,330 (Direct) |
View |
2024-11-26 Purchase |
2024-12-02 4:04 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
300,000 | $0.16667 | $50,000 | 1,020,203 (Direct) |
View |
2024-11-20 Sale |
2024-11-21 6:23 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
9,727 | $0.136 | $1,323 | 711,984 (Direct) |
View |
2024-11-20 Sale |
2024-11-21 6:21 pm |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
235 | $0.136 | $32 | 31,759 (Direct) |
View |
2024-11-20 Sale |
2024-11-21 6:20 pm |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
3,002 | $0.13591 | $408 | 72,968 (Direct) |
View |
2024-06-17 Sale |
2024-06-20 4:17 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
18,121 | $0.4578 | $8,296 | 676,203 (Direct) |
View |
2024-05-22 Sale |
2024-05-23 7:22 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
19,526 | $0.5753 | $11,233 | 694,324 (Direct) |
View |
2024-05-21 Sale |
2024-05-23 6:33 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
11,173 | $0.5972 | $6,673 | 1,413,240 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-31 Option Award |
2025-04-02 6:13 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
157,088 | $0 | 236,137 (Direct) |
View |
2025-03-31 Option Award |
2025-04-02 5:22 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
197,368 | $0 | 236,775 (Direct) |
View |
2025-03-31 Option Award |
2025-04-02 5:17 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer |
162,281 | $0 | 252,667 (Direct) |
View |
2025-03-31 Option Award |
2025-04-02 5:09 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
1,083,334 | $0 | 1,807,697 (Direct) |
View |
2025-03-26 Option Award |
2025-03-28 7:36 pm |
N/A N/A |
Oncology Institute Inc. | TOI | M33 Growth I L.P. M33 Growth I GP LLC Director 10% Owner |
2,716,898 | $1.0417 | 17,779,150 (Direct) |
View |
2025-03-26 Option Award |
2025-03-28 7:36 pm |
2025-03-26 2030-03-26 |
Oncology Institute Inc. | TOI | M33 Growth I L.P. M33 Growth I GP LLC Director 10% Owner |
1,358,449 | $0.125 | 17,779,150 (Direct) |
View |
2024-11-12 Other |
2024-12-02 4:04 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
353,450 | $0 | 1,020,203 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:38 pm |
N/A N/A |
Oncology Institute Inc. | TOI | BARASCH RICHARD A Director |
80,000 | $0 | 417,193 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:32 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Pacala Mark L Director |
50,000 | $0 | 134,409 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:28 pm |
N/A N/A |
Oncology Institute Inc. | TOI | McGeorge Anne Director |
56,000 | $0 | 183,346 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:26 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Johnson Karen Marie Director |
52,000 | $0 | 167,185 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:23 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Kaushal Mohit Director |
56,000 | $0 | 177,253 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:20 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Ling Gabriel Director |
40,000 | $0 | 109,057 (Direct) |
View |
2024-11-22 Option Award |
2024-11-25 4:14 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
44,000 | $0 | 720,203 (Direct) |
View |
2024-11-12 Other |
2024-11-18 6:54 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
28,398 | $0 | 104,368 (Direct) |
View |
2024-11-12 Other |
2024-11-18 6:52 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Pacala Mark L Director |
50,620 | $0 | 135,029 (Direct) |
View |
2024-11-12 Other |
2024-11-18 6:50 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
195,236 | $0 | 916,947 (Direct) |
View |
Ownership |
2024-09-30 4:30 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
0 | $0 | 121,388 (Direct) |
View |
2024-08-16 Other |
2024-08-20 06:15 am |
N/A N/A |
Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner |
16,333,241 | $0 | 16,585,867 (Indirect) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
694,810 | $0 | 1,413,240 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer |
530,107 | $0 | 853,579 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
61,355 | $0 | 148,193 (Direct) |
View |